Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Multiple shots on goal, they only need one for the value and share price of MTPH to soar, hence Zacks upgrade recently to £1 , of which, a good number of these shots on goal are close to fruition. It's possible they could all fail, but I do think at this late stage that is unlikely. Especial as Cantor Fitzgerald , Pope & Turner on board & investing heavily. Its been however a very frustrating ride, lets hope our patience is to be rewarded.
SS17 - how long have you been invested in Midatech?
Tried to buy 10k shares, waited 15 min , only managed to buy 1,309 shares at 19.50. The last trade is mine. No idea why it couldn’t buy full 10k I asked for ! Just Put a limit order for tomorrow max 20p let’s see . Rns seems positive hence wanted to top up
DYoR
WTF2012... disappointed... The BOD were talking about take over in the zoom call and going on the road to bring in Institutional Investors. All BS!
I think you are new to this stock. Dont post here much but very disappointed at the lake of progress.
Wouldn’t expect figures in this RNS, as this is a joint venture, which should pay a reasonable chunk of MTPHs Q-Sphera expenditure going forward this year + a 300%-400% multiple (see 24mins in https://www.youtube.com/watch?v=-Sfno8oYQYc). Hopefully a licensing deal at the start or end of the Phase I study, then we should see some figures (upfront, milestones, royalties).
well you clearly don't have a clue about how small pharma companies work, do you!
There are no figuars in the RNS. If there was something worth while why would the BOD not give some numbers. If we get a spike i want to sell out ASAP!
The managment are very lazy. They raised the money and went missing. This will most likly go down to 10p to 14p. Not sure anyone remember the zoom call severalmonths ago. They promised so much but did **** all! Once they got the money they went away. Still no material progress. This is AIM.
20p paid at last!
I expect to see some large out of hours trades from the odd lull this morning
Spread is 19 -20 but can buy for 19.2p
I added 30,000 but showing as a sell
Markets closed in case anyone was wondering
Just needs a little bit of volume and it'll be off into the 20's...
Ticking back up slowly, but getting there...early days yet..gla
The name of the big pharma was originally undisclosed, which is why you won't find a reference to Janssen. I guess now we know who we're dealing with.
it could be double or whatever more.... sentiment is bad here and that needs to change.. hopefully it will soon enough.. I'm surprised this went sub 20p in first place.. and I say that as a big cynic .. but if some up momentum comes back here then momentum can beget momentum on the way up like it has on the way down..
£12m market cap, raised £10m last June & had £4.2m of net cash pre raise, cash burn reducing across the board so should still have at least £10m now, if not more. The market cap simply doesn't make sense based on this mornings RNS.... surely it should be at least double the current level?
Bought a few more just now, 28,339 should should show up shortly. This brings my average down, but still alot under water.
On 17 June 2021, the Company announced that, using its Q-Sphera technology, it had successfully encapsulated a proprietary Janssen experimental large molecule medicine and importantly preserved its functional integrity.
===============
Cannot find reference to janssen in 17th June RNS
ps I added small more this morning.. im getting close to having doubled my bet here in recent weeks.. so Im certainly doing my bit here..
if it does extend the cash rumway in whatever shape or form - and it could of course, even if indirectly - then great if they'd said that in the RNS.. towards helping get some momentum back here... It can't be in a 'material' form or else they'd have said it for sure then.
this share is in a rut.. and decently progressive updates such as this seemingly aren't cutting it at this time, alas..
Should help extend the cash runway, and remove some uncertainty. Although being paid to develop products for the Janssen API's, most of the Q-Sphera development work they do, under the Janssen contract, will provide know how for developing other potential big pharma clients APIs. Wrote a post below about the options for the Big Pharma partner.. Announced today looks like Option 1 and hopefully therefore only a matter of time, all going well, before we move to option 2 (full licensing deal) or even 3 (buy-out - if allowable).. Janssen will know they are funding work that's increasing know how for Q-Sphera, and therefore potentially also helping competitors, if no excusive deal is done..
True! To think 28p was the last placing price shows how low we have gone
Wake me up wwhen 30p goes....gla
8% up
Still waiting on the big one though...gla